Structural modification of mevinolin
- 1 November 1982
- journal article
- research article
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 47 (24), 4750-4757
- https://doi.org/10.1021/jo00145a029
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Rapid and substantial lowering of human serum cholesterol by mevinolin (MK-803), an inhibitor of hydroxymethylglutaryl-coenzyme a reductaseAtherosclerosis, 1982
- Effects of an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase on Serum Lipoproteins and Ubiquinone-10 Levels in Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1981
- Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.Proceedings of the National Academy of Sciences, 1980
- Therapeutic effects of ML-236B in primary hypercholesterolemiaAtherosclerosis, 1980
- Hypolipidemic effects in monkeys of ML-236B, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductaseLipids, 1979
- Hypolipidemic effects in dogs of ML-236B, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductaseAtherosclerosis, 1979
- Crystal and molecular structure of compactin, a new antifungal metabolite from Penicillium brevicompactumJournal of the Chemical Society, Perkin Transactions 1, 1976
- Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart DiseaseAnnals of Internal Medicine, 1971